1858 — Beijing Chunlizhengda Medical Instruments Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Market Cap
HK$4.41bn
Enterprise Value
HK$2.45bn
Revenue
CNY805.86m

Annual income statement for Beijing Chunlizhengda Medical Instruments Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	938	1,108	1,202	1,209	806
Cost of Revenue
Gross Profit	681	844	900	855	516
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	608	741	873	903	675
Operating Profit	330	368	329	306	131
Other Net Non Operating Costs
Net Income Before Taxes	330	367	337	306	132
Provision for Income Taxes
Net Income After Taxes	283	322	308	278	125
Minority Interest
Net Income Before Extraordinary Items
Net Income	283	322	308	278	125
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	283	322	308	278	125
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.82	0.93	0.78	0.72	0.363
Dividends per Share